Zachary J. Meyer

Nov 4, 2024 | natlawreview.com | Townsend L. Bourne |Jordan Mallory |Zachary J. Meyer |Trevor Wong

Covering reported business bankruptcy filings in Massachusetts, Maine, New Hampshire, and Rhode Island, and Chapter 11 bankruptcy filings in New York and Delaware listing assets of more than $1 million. Because your business extends beyond the borders of a single state, ours does too.

Nov 4, 2024 | natlawreview.com | Zachary J. Meyer

With the election this week, there may be significant changes to the Strategic Outreach and Attraction Reserve (SOAR) Fund that support the state’s economic development initiatives. Enacted in December 2021, the SOAR Fund comprises the Critical Industry Program (CIP) and the Strategic Site Readiness Program (SSRP), but it faces uncertainty with future funding.

Oct 23, 2024 | varnumlaw.com | Timothy Gordon |Zachary J. Meyer |Peter Roth

On October 10, 2024, the Federal Trade Commission voted unanimously to issue its much-anticipated revisions to the Hart-Scott-Rodino (HSR) Act premerger notification form and related instructions (the Final Rule). Pending any legal challenges to the Final Rule, the Final Rule will go into effect 90 days following its publication in the Federal Register, which is anticipated in the coming days.

Jul 24, 2024 | natlawreview.com | Zachary J. Meyer

The ruling in American Hospital Association v. Becerra is good news for HIPAA-regulated entities that utilize third-party online tracking technologies. In short, the U.S. District Court for the Northern District of Texas ordered that by restricting HIPAA-regulated entities’ use of such technologies, the HHS had overstepped its authority. The District Court’s decision marks a victory for health care providers, as it will likely discourage similar litigation brought against HIPAA-regulated entities.

Jan 22, 2024 | natlawreview.com | Zachary J. Meyer

Although ownership and control of health care providers engaged in the practice of medicine has traditionally been limited to either non-profit enterprises or licensed medical professionals (and their regulated, professional enterprises), the industry in recent decades has seen an escalating infusion of capital from enterprises including private equity firms, and business structures have been created to accommodate funding from non-licensed, for-profit entities.